Dr. Spellman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12855 N 40 Dr
Ste 375
Saint Louis, MO 63141Phone+1 314-567-6071Fax+1 314-567-7961
Education & Training
University of Nebraska Medical Center College of MedicineResidency, Urology, 1999 - 2003- University of Nebraska Medical Center College of MedicineResidency, Surgery, 1997 - 1999
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1997
University of Notre DameBS, Biology, 1989 - 1993
Certifications & Licensure
IL State Medical License 2002 - 2026
MO State Medical License 2002 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 114 citationsERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.Stanislav Zelivianski, Matthew Spellman, Mark Kellerman, Vladimir Kakitelashvilli, Xia Wei Zhou
International Journal of Cancer. 2003-11-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
